These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1364937)

  • 1. Morning stiffness and nightime pain in ankylosing spondylitis. A comparison between enteric-coated and plain naproxen tablets.
    Johnsen V; Brun JG; Fjeld E; Hansen K; Sydnes OA; Ugstad MB
    Eur J Rheumatol Inflamm; 1992; 12(2):37-42. PubMed ID: 1364937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric-coated and plain naproxen tablets in osteoarthritis; tolerability and efficacy.
    Lehn OF; Jensen ON; Andersen LA; Christensen KA; Solheim L; Barslev J; Mjølstad W; Wiig G; Ibfelt HH; Kjønniksen T
    Eur J Rheumatol Inflamm; 1992; 12(2):31-6. PubMed ID: 1364936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic findings in the stomach and duodenum after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
    Oddsson E; Gudjonsson H; Thjodleifsson B
    Scand J Gastroenterol; 1990 Mar; 25(3):231-4. PubMed ID: 2181621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen-associated gastroduodenal toxicity: enteric coated granules versus plain tablets.
    Aabakken L; Ugstad M; Gamst ON; Winther R; Osnes M
    Eur J Rheumatol Inflamm; 1992; 12(2):43-8. PubMed ID: 1364939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A double blind comparison of naproxen and indomethacin on the after-midnight-pain of patients with morbus bechterew].
    Peter E
    Arzneimittelforschung; 1975 Feb; 25(2A):324-5. PubMed ID: 1096904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of morning stiffness in rheumatic patients after medication with enteric-coated and plain naproxen tablets.
    Johnsen V; Bjerkhoel F; Bjørneboe O; Børresen B; Finstad R; Hansen K; Moen F
    Scand J Rheumatol; 1986; 15(1):37-40. PubMed ID: 3515526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
    Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA
    Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of flurbiprofen with naproxen in ankylosing spondylitis.
    Burry HC; Siebers R
    N Z Med J; 1980 Oct; 92(670):309-11. PubMed ID: 7003449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of Butacote and naproxen in ankylosing spondylitis.
    Ansell BM
    J Int Med Res; 1977; 5 Suppl 2():95. PubMed ID: 334610
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
    Trondstad RI; Aadland E; Holler T; Olaussen B
    Scand J Gastroenterol; 1985 Mar; 20(2):239-42. PubMed ID: 3887555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results of a multicentral double-blind examination of naproxen compared to indomethacin in chronic rheumatoid arthritis, ankylosing spondylitis, and osteoarthrosis].
    Aeidler H
    Arzneimittelforschung; 1975 Feb; 25(2A):315-8. PubMed ID: 1096903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of enteric-coated naproxen tablets compared with standard naproxen tablets.
    Jung D; Schwartz KE
    Clin Ther; 1994; 16(6):923-9. PubMed ID: 7697688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Naproxen versus indomethacin as night-time medication for patients with rheumatoid arthritis].
    Wester JU; Haerslev T; Mathiesen FK; Jespersen SM; Hansen TM
    Ugeskr Laeger; 1991 Jul; 153(27):1937-9. PubMed ID: 1858176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of enteric and non-enteric coated naproxen tablets: a double-blind study in patients with osteoarthritis.
    Khong TK; Downing ME; Ellis R; Patchett I; Trayner J; Miller AJ
    Curr Med Res Opin; 1991; 12(8):540-6. PubMed ID: 1764957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butacote and naproxen: a comparison of effectiveness in rheumatoid arthritis.
    Million R
    J Int Med Res; 1977; 5 Suppl 2():77-80. PubMed ID: 334609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
    Katona G; Vargas RB
    Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.